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cAMPAbstract In this study, the effect of puriﬁed quercetin-3-O-b-D-glucopyranosyl-(1ﬁ 6)-b-D-glu-
copyranosid (QCGG) on melanogenesis was investigated. QCGG was isolated from the calyx of
a traditional Korean medicinal herb, Persimmon (Diospyros kaki). The hypopigmentation effects
of QCGG were determined by examination of cellular melanin contents, tyrosinase activity assay,
cAMP assay, and Western blotting of a-MSH-stimulated B16F10 mouse melanoma cells. Our
results showed that QCGG inhibited both melanin synthesis and tyrosinase activity in a concentra-
tion-dependent manner as well as signiﬁcantly reduced the expression of melanogenic proteins such
as microphthalmia-associated transcription factor (MITF), tyrosinase-related protein-1, tyrosinase-el.: +82
Do 461-
Quercetin-3-O-b-D-glucopyranosyl-(1ﬁ 6)-b-D-glucopyranoside suppresses melanin synthesis 707related protein-2, and tyrosinase. Moreover, QCGG inhibited intracellular cAMP levels, cAMP
response element-binding protein (CREB), and p38 MAPK expression in a-MSH-stimulated
B16F10 cells. Taken together, the suppressive effects of QCGG on melanogenesis may involve
down-regulation of MITF and its downstream signaling pathway via phosphorylation of p38
MAPK and CREB along with reduced cAMP levels. These results indicate that QCGG reduced
melanin synthesis by reducing expression of tyrosine and tyrosine-related proteins via extracellular
signal-related protein kinase (ERK) activation, followed by down-regulation of CREB, p38, and
MITF.
ª 2015 TheAuthors. Production and hosting by Elsevier B.V. on behalf ofKing SaudUniversity. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Mammalian melanocytes synthesize melanins in melanosomes,
which exist in the skin, eyes, and hair. There are four chro-
mophores that determine the skin color (carotenoids, haemo-
globin, oxyhaemoglobin, and melanins), of which melanins
are the predominant component (Kameyama et al., 1995;
Hearing, 2005). In humans, hyperpigmentation occurs after
stimulation by ultraviolet radiation or solar light, conﬁrming
that the function of melanin is to protect the skin from
ultraviolet radiation (Tsatmali et al., 2002). Melanogenesis,
or melanin biosynthesis within melanosomes, is mainly regu-
lated by enzymes such as tyrosinase-related protein-1 (TRP-
1), tyrosinase-related protein-2 (TRP-2), and tyrosinase
(Kameyama et al., 1995). Among them, tyrosinase plays two
important rate-limiting steps during melanin biosynthesis
(Hearing and Jimenez, 1987). The tyrosinase family genes
TRP-1 and TRP-2 are transcriptionally regulated by micro-
phatalmia-associated transcription factor (MITF), which sug-
gests that MITF is an important transcription regulator
during melanogenesis (Tachibana, 2001; Levy et al., 2006;
Ye et al., 2010; Tsang et al., 2012). Previously, researchers have
documented that mitogen-activated protein kinases (MAPKs)
consist of a family of serine/threonine kinases, including p38
MAPK, extracellular response kinase (ERK), and c-Jun N-
terminalkinase (JNK), which play important roles in melano-
genesis (Seger and Krebs, 1995; Cohen, 1997; Jiang et al.,
2009). Recent investigations have reported that p38 MAPK
is particularly involved in MITF regulation (Saha et al.,
2006). In addition, activation of the p38 MAPK signaling
pathway increases the transcription of tyrosinase, which acti-
vates melanin synthesis (Corre and Galibert, 2005; Singh
et al., 2005). The second messenger cAMP derived from
ATP plays an important function in intracellular signal trans-
duction (Park et al., 2006). Increased cAMP level affects pro-
tein kinase A (PKA), cAMP response element-binding protein
(CREB), and cAMP response element (CRE) located in M
promoter of MITF (Tachibana, 2000). cAMP-related biologi-
cal effects depend on PKA, which has a direct inﬂuence on
melanogenesis. PKA activation can cause MITF expression
via phosphorylation of CREB, which increases melanin
synthesis (Busc and Ballotti, 2000).
Tyrosinase inhibitors have gained attention due to the
major role of tyrosinase in melanogenesis (Chang, 2009).
Some tyrosinase inhibitors such as kojic acid and arbutin are
involved in cosmetic products (Smit et al., 2009). Although kojic
acid has no carcinogenic activity such as the commonly used
whitening agent hydroquinone, dermatologists have reportedthat long and persistent use of kojic acid can produce severe der-
mal problems such as itchiness, red rash, and irritation. Herbal
medicines are a largely unexplored material for developing new
and safe ingredients that can antagonize tyrosinase activity
(Kiken and Cohen, 2002; Pieroni et al., 2004).
Persimmon (Diospyros kaki), belonging to Ebenaceae, is a
famous conventional Korean medicinal herb. Persimmon calyx
has been used to prepare herbal drinks in Korea, China, and
Japan due to its abundance of fructose, glucose, and triter-
penoid. Persimmon calyx is also generally used as a traditional
medicine in Korea to relieve asthma, chronic bronchitis, and
cough symptoms (Bei et al., 2009; Sa et al., 2005; Sakanaka
et al., 2005). Persimmon leaves have been reported to have
various biological effects such as microbial inhibition, radical
scavenging, neuroprotection, blood pressure reduction, and
thrombosis inhibition (Bei et al., 2009; Sakanaka et al., 2005;
An et al., 2005; Byun et al., 2010). Previously, we reported that
ﬂavonoid constituents from leaves of persimmon have collagen
biosynthesis activity in human skin ﬁbroblasts (Duthie and
Dobson, 1999). Since most studies have focused on the leaves
and fruits of persimmon, there are limited data available on its
chemical components and biological potential. Therefore, we
focused on the isolation and characterization of the active
components of persimmon calyx. Quercetin (QC), which is
found in fruits, vegetables, and grains, is one of the most com-
mon dietary ﬂavonoids (Olszewska, 2008). Previous reports
showed that QC induces apoptosis of cancer cells, inhibits pro-
tein-kinase C (Murota and Terao, 2003), and modulates redox
status (Garcia-Mediavilla et al., 2007). Here, another deriva-
tive of QC, quercetin-3-O-b-D-glucopyranosyl-(1ﬁ 6)-b-D-
glucopyranoside (QCGG), was isolated from the calyx of per-
simmon for the ﬁrst time. Therefore, we aimed to determine
the effect of QCGG on melanin synthesis and its underlying
signaling pathways in alpha-melanocyte-stimulating hormone
(a-MSH)-stimulated B16F10 cells.
2. Materials and methods
2.1. Reagents
Sephadex LH-20 column of 25–10 lm was purchased from
Pharmacia (Stockholm, Sweden), MCI-gel CHP 20P column
of 75–150 lm was purchased from Mitsubishi (Tokyo, Japan),
and YMC-gel ODS-A column of 230–70 and 500–400 mesh
were purchased from YMC Co (PA, USA). Dimethylsulfoxide
(DMSO), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT), L-DOPA, alpha-melanocyte stimulating hor-
mone (a-MSH), and phosphate-buffered saline (PBS) were
708 H.G. Jung et al.purchased from Sigma–Aldrich (St. Louis, MO, USA).
Dulbecco’s modiﬁed Eagle’s medium (DMEM) and fetal bovine
serum (FBS) were obtained from Invitrogen–Gibco (Grand
Island, NY, USA). Antibodies against MITF, tyrosinase,
TRP-1, TRP-2, phospho-p38 MAPK, p38 MAPK, phospho-
ERK, ERK, phospho-JNK, JNK, phospho-CREB, and
CREB purchased from Santa Cruz Biotechnology (Santa
Cruz, CA, USA). Anti-mouse and anti-goat IgG antibodies
were purchased from Cell Signaling Technology (Beverly,
MA, USA). The cAMP assay kit was purchased from
Cayman Chemical (Ann Arbor, MI). All other reagents were
purchased from Sigma–Aldrich Chemical Co. (St. Louis, MO,
USA).
2.2. Plant materials
Persimmon calyx was collected from Dae-Bo Korea
Traditional Parmacy in Yeongcheon, Gyeungbuk, Korea in
October 2009. A voucher specimen (PC 2010-02) has been
deposited at the herbarium of the Department of
Cosmeceutical Science, Daegu Haany University.
2.3. Extraction and isolation
The air-dried calyx (4.0 kg) was extracted three times with
70% aqueous acetone at room temperature. After removing
acetone under vacuum, the aqueous solution was ﬁltered.
The ﬁltrate was then concentrated and applied to a
Sephadex LH-20 column (2 kg, 10 · 70 cm) containing
increasing proportions of EtOH, yielding ﬁve fractions.
Repeated column chromatography of fraction 2 (1.9 g) on
MCI-gel CHP 20P (75–150 nm, 5 · 60 cm) with a H2O-100%
MeOH gradient produced Fr. 2–2 (0.98 g), which was sub-
jected to ﬁnal puriﬁcation using YMC-ODS gel (12 nm,
600 g, 5 · 60 cm) with a 20–100% MeOH gradient to produce
compound 1 (500 mg).
2.4. Thin layer chromatography (TLC) and nuclear magnetic
resonance (NMR)
TLC was carried out on a pre-coated silica gel 60 F254 plate
(Merck). The spots were detected under UV radiation and
by spraying with FeCl3 and 10% H2SO4, followed by heating.
The 1H- and 13C NMR spectra were recorded on a Varian
Unity NMR at 500 MHz and 125 MHz (13C- NMR). The
chemical shifts are shown in d (ppm) relative to TMS. The
structure of 1 was identiﬁed as quercetin-3-O-b-D-glu-
copyranosyl-(1ﬁ 6)-b-D-glucopyranoside by comparison of
its physicochemical and spectroscopic data (1H, and 13C
NMR) with literature values.
2.5. Cell culture
B16F10 mouse melanoma cells (CRL 6323) were obtained
from the American Type Culture Collection (Manassas, VA,
USA). Cells were cultured in Dulbecco’s modiﬁed Eagle’s med-
ium (DMEM; Gibco Life Technologies, France) supplemented
with 10% fetal calf serum and 1% penicillin/streptomycin in a
5% CO2 humidiﬁed incubator at 37 C.2.6. Cell viability assay
The general viability of cultured cells was determined through
reduction of MTT to formazan. After QCGG treatment, cells
were incubated for 48 h at 37 C in an atmosphere containing
5% CO2. MTT (1 mg/ml in phosphate-buffered saline; PBS)
was then added to each well at 10% of the medium volume.
Cells were incubated at 37 C for 3 h, and dimethyl sulfoxide
(DMSO) was added to dissolve the formazan crystals. The
absorbance was measured at 570 nm using a Spectra MAX
190 spectrophotometer (Molecular Devices, Sunnyvale, CA,
USA).
2.7. Measurement of cellular melanin contents
The melanin content was measured by slight modiﬁcation of a
previously described method (Tsuboi et al., 1998). Brieﬂy, cells
were washed with PBS and then dissolved in 1 N NaOH in
10% DMSO at 80 C for 1 h. The relative melanin content
was determined by measuring the absorbance at 475 nm in
an enzyme-linked immunosorbent assay (ELISA) reader. The
value of each measurement was expressed as percentage
changes from the control.
2.8. Tyrosinase activity assay
Tyrosinase activity was estimated by measuring the rate of l-
DOPA oxidation (Tomita et al., 1992). Brieﬂy, cells were lysed
by incubation at 37 C for 30 min in RIPA buffer (0.1 M
sodium phosphate, pH 7.0, 1% Triton X-100, 0.1 mM phenyl-
methanesulfonylﬂuoride (PMSF), 1 mM NaF). The lysates
were then centrifuged at 10,000·g for 20 min to obtain the
supernatant as crude tyrosinase extract for the activity assay.
The reaction mixture contained 0.1 M sodium phosphate
(pH 7.0), 0.05% l-DOPA, and the supernatant (tyrosinase
source). After incubation at 37 C for 1 h, dopachrome was
monitored by measuring the absorbance at 405 nm in an
ELISA reader. The value of each measurement was expressed
as percentage changes from the control.
2.9. Western blotting
B16F10 cells were treated with QCGG, and cells were cultured
and harvested using RIPA buffer containing 20 mM Tris–HCl,
pH 8.0, 150 mM NaCl, 1% NP-40, 2 mM EDTA, 1 mM
PMSF, 10 mM NaF, 1 mM Na3VO4, and protease inhibitors
(Sigma, USA). Protein concentrations were then determined
using Bradford Assay (Bio-Rad, Richmond, CA, USA), after
which 30 g of protein was separated by electrophoresis on a
10% SDS–polyacrylamide gel and then transferred to a nitro-
cellulose membrane (Whatman, Germany). The membrane
was blocked with 5% skim milk and incubated with MITF,
tyrosinase, TRP-1, TRP-2, phospho-p38 MAPK, p38
MAPK, phospho-ERK, ERK, phospho-JNK, JNK, phos-
pho-CREB, CREB, and GAPDH antibodies (diluted
1:1000). All bands were visualized using horseradish peroxi-
dase-conjugated secondary antibodies (1:1000, Santa Cruz
Biotech, CA, USA) using an enhanced chemiluminescence sys-
tem (Pierce Biotech, Rockford, IL, USA). Western blotting
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experiments.
2.10. Measurement of cAMP levels
Cells were serum-starved overnight and then treated with
QCGG (10–100 lg/ml). After treatment, cells were lysed in
0.1 M HCl. Cell debris was then removed by centrifugation
(1000 g, 15 min), after which the supernatant was subjected
to determination of cAMP levels using a commercially avail-
able cAMP EIA kit (Cayman Chemical, Ann Arbor, MI).
cAMP levels were normalized to total protein content.
2.11. Statistical analysis
Data are presented as mean ± standard deviation. One-way
ANOVA followed by Tukey’s post hoc test was performed
using SPSS software (version19) to determine the statistical
signiﬁcance between the groups. The results were considered
statistically signiﬁcant at *P< 0.05 and **P< 0.01.
3. Results
3.1. Identiﬁcation of quercetin-3-O-b-D-glucopyranosyl-
(1ﬁ 6)-b-D-glucopyranoside
Yellow amorphous powder; 1H-NMR (500 MHz, CD3OD) d:
7.91 (1H, d, J= 1.8 Hz, H-20), 7.62 (1H, dd, J= 8.4, 1.8 Hz,
H-60), 6.98 (1H, d, J= 8.4 Hz, H-50), 6.53 (1H, d,
J= 1.8 Hz, H-8), 6.29 (1H, d, J= 1.8 Hz, H-6), 5.22 (1H, d,
J= 8.4 Hz, H-100), 3.93 (1H, d, J= 7.2 Hz, H-100 0); 13C-
NMR (CD3OD, 125 MHz) d: 178.6 (C-4), 165.7 (C-7), 161.9
(C-5), 157.8 (C-9), 157.5 (C-2), 149.2 (C-40), 145.0 (C-30),
134.9 (C-3), 122.1 (C-60), 121.9 (C-10), 117.4 (C-20), 115.5 (C-
50), 104.8 (C-10), 104.6 (C-100), 103.9 (C-100 0), 99.5 (C-6), 94.5
(C-8), 77.4 (C-300), 77.3 (C-500 0), 76.2 (C-300 0), 74.9 (C-500), 74.2
(C-200), 72.4 (C-200 0), 70.1 (C-400), 68.7 (C-400 0), 61.7 (C-600),
60.8 (C-600 0) (Figure 1).
3.2. Effect of QCGG on B16F10 cell viability
To assess the effect of QCGG on cell viability, B16F10 mela-
noma cells were treated with various concentrations of
QCGG (10–100 lg/ml) for 48 h (Figure 2A). MTT assay is a
colorimetric assay that measures enzyme activity related to
reduction of MTT to formazan dyes, which are purple in color.
Results are expressed as percent viability relative to controlFigure 1 Chemical structure of quercetin-3-O-b-D-glucopyrano-
syl-(1ﬁ 6)-b-D-glucopyranoside (QCGG).(0 lg/ml). According to our results, QCGG had no signiﬁcant
effect on cell mortality (101% at 10 lg/ml, 100% at 50 lg/ml,
and 104% at 100 lg/ml).
3.3. Effect of QCGG on melanin content of B16F10 cells
To determine the effect of QCGG on melanogenesis, B16F10
melanoma cells were exposed to a-MSH (100 nM) alone or
with QCGG (0–100 lg/ml) for 48 h. Treatment with QCGG
at 10–100 lg/ml had a signiﬁcant inhibitory effect on melanin
synthesis in a dose-dependent manner in B16F10 melanoma
cells pretreated with a-MSH. Melanin content was represented
as a percentage of control (0 lg/ml of QCGG). After treat-
ment, melanin content decreased gradually to 80.11% at
10 lg/ml, 78.46% at 50 lg/ml, and 58.41% at 100 lg/ml
(Figure 2B). This result indicates that QCGG has a potent
inhibitory effect on melanin formation in B16F10 melanoma
cells.
3.4. Inhibitory effect of QCGG on tyrosinase activity in B16F10
cells
To more precisely examine the possible mechanism of the inhi-
bitory effect of QCGG on melanogenesis, we assessed intra-
cellular tyrosinase activity in B16F10 melanoma cells. Cells
were exposed to a-MSH (100 nM) alone or with QCGG (0–
100 lg/ml) for 48 h. QCGG at 10–100 lg/ml inhibited a-
MSH-induced tyrosinase activity in a dose-dependent pattern
(Figure 4). After treatments, remaining B16F16 intracellular
tyrosinase activity was 94.91% at 10 lg/ml, 89.54% at 50 lg/
ml, and 87.26% at 100 lg/ml. The results shown in
Figure 3A were in accordance with those indicated in
Figure 2B, which means that QCGG inhibited intracellular
tyrosinase activity and then reduced melanin content in a
dose-dependent manner in B16F10 melanoma cells.
3.5. Effect of QCGG on cellular melanogenesis-related protein
expression
Many proteins are involved in tyrosinase expression, including
microphthalmia-associated transcription factor (MITF),
tyrosinase-related protein-1 (TRP-1), and tyrosinase-related
protein-2 (TRP-2). To test whether or not QCGG regulates
expression of these proteins, B16F10 melanoma cells were
exposed to a-MSH (100 nM) alone or with QCGG (0–
100 lg/ml) for 48 h. MITF, tyrosinase, TRP-1, and TRP-2
levels were assayed by Western blotting (Figure 3B). QCGG
treatment dramatically reduced MITF, TRP-1, TRP-2, and
tyrosinase levels in a-MSH-stimulated B16F10 melanoma cells
(Figure 3B).
3.6. QCGG suppresses melanin synthesis through cAMP
signaling down-regulation and melanogenesis-related signaling
pathways
In our results, QCGG induced down-regulation of MITF,
tyrosinase, TRP-1, and TRP-2 expression in a-MSH-
stimulated B16F10 cells. a-MSH, which is an adenyl cyclase
activator, can increase intracellular cAMP levels and conse-
quently activate tyrosinase regulation and melanin synthesis
Figure 2 Effect of QCGG on (A) B16F0 cell viability. B16F0 melanoma cells were treated with various concentrations of QCGG for
48 h. Cell viability was determined using MTT assay. Each percentage value in treated cells was calculated with respect to that in control
cells; (B) cellular melanin synthesis in B16F0 cells. Cells were exposed to a-MSH (100 nM) alone or plus with QCGG (0–100 lg/ml) for
48 h. Each percentage value for treated cells was reported relative to that of control cells. Values are the mean ± SD of duplicate
determinations from three separate experiments. *P< 0.05, **P< 0.01 compared with the control.
Figure 3 Effect of QCGG on (A) tyrosinase in B16F0 cells exposed to a-MSH (100 nM) alone or with QCGG (0–100 lg/ml) for 48 h.
Each percentage value for treated cells was reported relative to that of control cells; (B) expression of melanogenesis-related proteins in
B16F0 cells. B16F0 cells were exposed to a-MSH (100 nM) alone or with QCGG (0–100 lg/ml) for 48 h. Expression levels of MITF, TRP-
1, TRP-2, and tyrosinase were measured by Western blotting using speciﬁc antibodies. Equal protein loading was checked by GAPDH.
Representatives of three independent experiments are shown. Values are the mean ± SD of duplicate determinations from three separate
experiments. *P< 0.05, **P< 0.01 compared with the control.
710 H.G. Jung et al.(Abdel-Malek et al., 1999; Bertolotto et al., 1998; Costin and
Hearing, 2007). Hence, we investigated whether or not the
inhibitory mechanism of QCGG is involved in cAMP-depen-
dent signaling in a-MSH-stimulated B16F10 cells. B16F10
cells were exposed to a-MSH (100 nM) alone or with QCGG
(0–100 lg/ml) for 48 h prior to measurement of intracellular
cAMP levels. As shown in Figure 4A, QCGG treatment
dose-dependently reduced cAMP levels in a-MSH-stimulated
B16F10 cells. These results suggest that the inhibitory effect
of QCGG during melanogenesis may be related to down-reg-
ulation of a-MSH-induced cAMP signaling. To further inves-
tigate the relationship between QCGG-induced melonogenic
inhibitory activity and cAMP-related signaling pathway, we
performed Western blotting to assess phosphorylation levels
of p38 MAPK, ERK, JNK, and CREB. As shown inFigure 4B, phosphorylation of p38 MAPK and CREB were
dose-dependently inhibited in a-MSH-stimulated B16F10 cells
at 48 h. These results suggest that the inhibitory effect of
QCGG may be related to inhibition by p38 MAPK and
CREB phosphorylation.4. Discussion
Melanin plays an important role in protecting human skin
from unwanted UV radiation from sunlight as well as toxic
effects of drugs and chemicals. The accumulation of unwanted
melanin in a speciﬁc body parts (melasma and freckles) may
become problems with age. In Asian countries, many women
dislike hyperpigmentation such as melasma and freckles, as
Figure 4 Effect of QCGG on (A) intracellular cAMP accumulation in B16F10 cells. Cells were exposed to a-MSH (100 nM) alone or
with QCGG (0–100 lg/ml) for 48 h. Intracellular cAMP levels were measured using an enzyme immunoassay protocol; (B) expression
levels of MAPKs, phosphorylated-MAPKs, CREB, and phosphorylated-CREB in B16 cells. Cells were exposed to a-MSH (100 nM)
alone or with QCGG (0–100 lg/ml) for 48 h. Protein expression was determined by Western blotting. Equal protein loading was checked
by GAPDH. Representatives of three independent experiments are shown. Results shown are means ± SEM and are representative of
three independent experiments. *P< 0.05, **P< 0.01 compared with the control.
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taining beauty. Many whitening agents have been reported and
are used in cosmetics and medical applications to treat skin
and pigment abnormalities. However, some of these agents
such as hydroquinone and mercury have cytotoxicity or
undesirable side effects on the skin. Hydroquinone is known
to induce allergic reactions, redness of the skin, and skin light-
ening cream containing mercury is known to be associated
with kidney damage, skin rashes, discoloration, as well as
reduced skin resistance capabilities against bacterial and fun-
gal infection. These adverse effects of commonly used skin
lightening agents have forced researchers to search for safe,
effective, and natural whitening agents (Ladizinski et al.,
2011). In this study, we demonstrated the inhibitory mecha-
nism of QCGG isolated from persimmon calyx in a-MSH-
stimulated B16F10 melanoma cells.
In humans, variations in skin color occur due to skin mel-
anin. Melanin content correlates directly with tyrosinase activ-
ity and tyrosinase-related protein levels (Maeda et al., 1997;
Shibahara et al., 2000). Therefore, as a ﬁrst step to determining
the effects of QCGG on a-MSH-induced melanogenesis, we
investigated whether or not QCGG could inhibit melanin syn-
thesis in the presence of a-MSH. We found that QCGG signiﬁ-
cantly inhibited melanin synthesis, as tyrosinase and
tyrosinase-related protein levels were down-regulated in a
dose-dependent manner (Figs. 2B and 3A). Cell viability
assay of QCGG showed a lack of cytotoxic effects on
B16F10 cells (Figure 2A). These results suggest that QCGG
may be a safe alternative skin lightener agent for down-reg-
ulation of tyrosinase activity and inhibition of cellular melanin
synthesis in B16F10 cells.
Generally, a-MSH potently inﬂuences MITF expression via
activation of TRP-1, TRP-2, and tyrosinase activity, resulting
in increased melanin synthesis (Abdel-Malek et al., 1999;
Bertolotto et al., 1998; Costin and Hearing, 2007). Therefore,
down-regulation of MITF via TRP-1, TRP-2, and tyrosinase
is the most important factor affecting the anti-melanogenicability of any compound. To elucidate the mechanisms under-
lying the anti-tyrosinase and anti-melanogenic activities of
QCGG, we ﬁrst examined the effects of QCGG on expression
of melanogenic enzymes (TRP-1, TRP-2, and tyrosinase) by
Western blotting. As shown in Figure 3B, QCGG at 10–
100 lg/ml dose-dependently reduced expression of TRP-1,
TRP-2, and tyrosinase at 48 h. Since these three enzymes are
transcriptionally regulated by MITF, we next examined the
effect of QCGG on MITF expression. Results showed that
QCGG dramatically and dose-dependently inhibited MITF
expression in B16F10 cells (Figure 3B). These results suggest
that the inhibitory effects of QCGG coordinated MITF,
TRP-1, TRP-2, and tyrosinase down-regulation in B16F10
cells. Thus, the inhibitory effect of QCGG is accompanied
by corresponding down-regulation of MITF expression, which
consequently reduces melanogenic protein expression.
For improved understanding of the inhibitory effect of
QCGG on a-MSH-induced melanogenesis, we explored
whether or not QCGG could affect the intracellular cAMP
level induced by a-MSH, as promotion of cAMP up-regulates
MITF expression. MITF has been shown to speciﬁcally bind
to the M and E box motifs as well as up-regulate tyrosinase,
TRP-1, and TRP-2 promoter activities, eventually leading to
enhanced melanin synthesis (Abdel-Malek et al., 1999;
Bertolotto et al., 1998; Costin and Hearing, 2007). Therefore,
the regulation of a-MSH-induced cAMP signaling is thought
to be potentially important for regulating hyperpigmentation.
In accordance with this view, QCGG dose-dependently
reduced the intracellular cAMP level in a-MSH-stimulated
B16F10 melanoma cells (Figure 4A). This observation sug-
gests that QCGG profoundly suppresses expression of MITF
through down-regulation of cAMP levels, resulting in reduced
melanin content and tyrosinase activity in a-MSH-stimulated
B16F10 melanoma cells.cAMP has been reported to inhibit
the MAP kinase pathway in numerous cell types. However,
it has been shown that cAMP up-regulation activates MAPK
in B16 melanoma cells as well as normal human melanocytes
712 H.G. Jung et al.(Busca` et al., 1999). The cAMP signaling pathway is modu-
lated through a PI3 K-dependent mechanism via both the
MAPK and PKA pathways during melanin synthesis.
Intracellular cAMP binds to two regulatory subunits of pro-
tein kinase A (PKA). After phosphorylation of its substrate
by PKA, translocates to nucleus where it phosphorylates
cAMP response element (CRE), there by phosphorylate
CREB (Khaled et al., 2003). To better understand the inhibi-
tory mechanism of QCGG in a-MSH-induced cAMP-depen-
dent MITF signaling, we investigated the effect of QCGG
treatment on activation of p38 MAPK, JNK, ERK, and
CREB using Western blotting. Results showed that although
phosphorylation of ERK and JNK were unaffected, phospho-
rylation of p38 MAPK and CREB was dose-dependently
reduced by QCGG at 48 h. In addition, QCGG treatment
did not signiﬁcantly alter expression levels of p38 MAPK,
ERK, JNK, and CREB (Figure 4B). Negative results for the
effect of QCGG treatment on ERK and JNK phosphorylation
suggest that ERK and JNK do not participate in the anti-
melanogenic activity of QCGG.5. Conclusion
In conclusion, QCGG primarily inhibits cellular melanin pro-
duction and tyrosinase activity in B16F10 cells by suppressing
the expression of MITF, TRP-1, TRP-2, and tyrosinase
through p38 MAPK and CREB. Moreover, we found that
the QCGG-induced inhibitory effect on melanogenesis could
be attributed to suppression of intracellular cAMP production.
Therefore, QCGG may be a useful therapeutic agent for the
treatment of hyperpigmentation, and could be used as an
ingredient in whitening and lightening cosmetics. However, it
should be noted that safety is a primary consideration before
practical use in humans.References
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